Mary J. van Helden
- Immunology top 5%
- Molecular Biology
- Oncology
- Biophysics top 2%
- Hematology top 10%
- Co-authors
- Bart N. LambrechtSofie Van GassenPiet DemeesterTom DhaeneYvan SaeysSofie De PrijckLouis BoonÉric Vivier
- Topics
- IL-33, ST2, and ILC Pathways (3 papers)Immune Cell Function and Interaction (3 papers)Asthma and respiratory diseases (2 papers)
- Cited by
- BiophysicsImmunologyHematology
- Partner nations
- BelgiumNetherlandsFrance
In The Last Decade
Mary J. van Helden
5 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 105
- Immunology 591
- Molecular Biology 471
- Oncology 196
- Biophysics 160
- Hematology 90
Countries citing papers authored by Mary J. van Helden
This map shows the geographic impact of Mary J. van Helden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary J. van Helden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary J. van Helden more than expected).
Fields of papers citing papers by Mary J. van Helden
This network shows the impact of papers produced by Mary J. van Helden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary J. van Helden. The network helps show where Mary J. van Helden may publish in the future.
Co-authorship network of co-authors of Mary J. van Helden
This figure shows the co-authorship network connecting the top 25 collaborators of Mary J. van Helden. A scholar is included among the top collaborators of Mary J. van Helden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary J. van Helden. Mary J. van Helden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 20 | |
| 3 | 2 | |
| 4 | FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry databreakdown → | 1037 |
| 5 | 52 |
About Mary J. van Helden
Mary J. van Helden is a scholar working on Immunology, Biophysics and Hematology, having authored 5 papers that have together received 1.1k indexed citations. Recurring topics across this work include IL-33, ST2, and ILC Pathways (3 papers), Immune Cell Function and Interaction (3 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Biophysics (160 citations), Immunology (591 citations) and Hematology (90 citations). Mary J. van Helden has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Bart N. Lambrecht, Sofie Van Gassen, Piet Demeester, Tom Dhaene, Yvan Saeys, Sofie De Prijck, Louis Boon, Éric Vivier, Kim Deswarte and Justine Van Moorleghem. Their work appears in journals such as The Journal of Experimental Medicine, Scientific Reports and Current Opinion in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.